INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $258,000 | -23.4% | 1,931 | -7.3% | 0.01% | -12.5% |
| Q2 2021 | $337,000 | +137.3% | 2,082 | +18.0% | 0.02% | +128.6% |
| Q1 2021 | $142,000 | +105.8% | 1,764 | -49.8% | 0.01% | +75.0% |
| Q3 2020 | $69,000 | -13.8% | 3,517 | -8.9% | 0.00% | -20.0% |
| Q2 2020 | $80,000 | +7900.0% | 3,860 | +3507.5% | 0.01% | – |
| Q1 2020 | $1,000 | -50.0% | 107 | -10.1% | 0.00% | – |
| Q2 2019 | $2,000 | – | 119 | +981.8% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 11 | -85.7% | 0.00% | – |
| Q1 2018 | $2,000 | -66.7% | 77 | -73.9% | 0.00% | -100.0% |
| Q4 2017 | $6,000 | +50.0% | 295 | +74.6% | 0.00% | – |
| Q3 2017 | $4,000 | -20.0% | 169 | -46.9% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 318 | -17.8% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 387 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | – | 387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |